These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30932948)

  • 1. Immediate-Release Methylphenidate-Associated Recurrent Nasal Bleeding in Siblings.
    Chandradasa M; Rathnayake LC
    J Clin Psychopharmacol; 2019; 39(3):284-285. PubMed ID: 30932948
    [No Abstract]   [Full Text] [Related]  

  • 2. Nasal Bleeding Probably Associated with Methylphenidate.
    Avcil S
    J Child Adolesc Psychopharmacol; 2017 Dec; 27(10):924-925. PubMed ID: 29131668
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter to the editor: Comment on 'Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder'.
    Olders H
    J Pediatr Psychol; 2009; 34(1):108-9; author reply 110-2. PubMed ID: 19136567
    [No Abstract]   [Full Text] [Related]  

  • 4. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
    Killeen MR
    J Child Fam Nurs; 2000; 3(1):46-8. PubMed ID: 11022478
    [No Abstract]   [Full Text] [Related]  

  • 5. Methylphenidate-induced erections in a prepubertal child.
    Kelly BD; Lundon DJ; McGuinness D; Brady CM
    J Pediatr Urol; 2013 Feb; 9(1):e1-2. PubMed ID: 22552161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate transdermal system in attention-deficit hyperactivity disorder in children: A viewpoint by Raul R. Silva.
    Silva RR
    Drugs; 2006; 66(8):1127-8; discussion 1128. PubMed ID: 16789798
    [No Abstract]   [Full Text] [Related]  

  • 7. Methylphenidate-Induced Raynaud Phenomenon Developed After Increasing Methylphenidate in an Adult With Attention-Deficit Hyperactivity Disorder.
    Monteerarat Y; Pariwatcharakul P
    J Clin Psychopharmacol; 2019; 39(2):178-179. PubMed ID: 30811376
    [No Abstract]   [Full Text] [Related]  

  • 8. Is There an Effect of Methylphenidate on Thrombocytopenia?
    Ercan ES; Inci SB; Ipci M
    J Clin Psychopharmacol; 2017 Jun; 37(3):374. PubMed ID: 28301399
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P; Sever J; Weizman A
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulants for ADHD in child patients with Tourette's syndrome: the issue of relative risk.
    Gadow KD; Sverd J
    J Dev Behav Pediatr; 1990 Oct; 11(5):269-71; discussion 272. PubMed ID: 1979565
    [No Abstract]   [Full Text] [Related]  

  • 11. Resolution of methylphenidate osmotic release oral system-induced hair loss in two siblings after dose escalation.
    Ardic UA; Ercan ES
    Pediatr Int; 2017 Nov; 59(11):1217-1218. PubMed ID: 29359460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excessive masturbation and hypersexual behavior associated with methylphenidate.
    Bilgiç A; Gürkan K; Türkoğlu S
    J Am Acad Child Adolesc Psychiatry; 2007 Jul; 46(7):789-90. PubMed ID: 17581441
    [No Abstract]   [Full Text] [Related]  

  • 13. QuilliChew ER--extended-release chewable methylphenidate tablets.
    Med Lett Drugs Ther; 2016 May; 58(1495):68-9. PubMed ID: 27192619
    [No Abstract]   [Full Text] [Related]  

  • 14. Methylphenidate transdermal system.
    Mays DA; Findling R
    J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1223. PubMed ID: 16292112
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular effects of methylphenidate.
    Daniels SR
    J Pediatr; 2009 Jul; 155(1):A3. PubMed ID: 19559283
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversible ischaemic neurological deficit associated with short-term methylphenidate medication.
    Leonhard C; Reif A; Beck M; Jacob C; Lesch KP
    Int J Neuropsychopharmacol; 2006 Feb; 9(1):129-30. PubMed ID: 16004621
    [No Abstract]   [Full Text] [Related]  

  • 17. Aptensio XR--another long-acting methylphenidate.
    Med Lett Drugs Ther; 2015 Jul; 57(1473):101-3. PubMed ID: 26204039
    [No Abstract]   [Full Text] [Related]  

  • 18. OROS methylphenidate-induced skin eruptions.
    Coskun M; Tutkunkardas MD; Zoroglu S
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):593-4. PubMed ID: 19877987
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder.
    Cox DJ; Mikami AY; Cox BS; Coleman MT; Mahmood A; Sood A; Moore M; Burket R; Merkel RL
    Arch Pediatr Adolesc Med; 2008 Aug; 162(8):793-4. PubMed ID: 18678816
    [No Abstract]   [Full Text] [Related]  

  • 20. Transdermal methylphenidate (Daytrana) for ADHD.
    Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.